NASDAQ · SUJA

Suja Life, Inc.

$10.40 +$0.54 (+5.48%) 1D After hours

Key Metrics

$234.56M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    From its May 7 high, the share price fell 50%.

    Peak close $17.85 on May 7; trough close $8.96 on Jul 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -50%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved -25.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10
  • May 14
    The stock moved -14.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$234.56M
Enterprise value
Shares outstanding23.8M
52-wk range$8.71 – $18.48
Avg volume · 20D394.1K
Net cash
Book value / share
IndustryBeverages
ExchangeNASDAQ
About Suja Life, Inc.
IPO dateMay 7, 2026
Employees

Suja Life Inc operates a beverage platform focused on producing and selling products such as cold-pressed juices, wellness shots, and functional sodas. Its portfolio includes brands such as Suja Organic, Vive Organic, and Slice.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-30 · computed by TickerWolf from SEC filings